Ticker
OVIDCompany Name
OVID THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -0.08% | $ 61.01M | $ 51K |
3/31/2025 | -2% | $ 20.34M | $ 407K |
12/31/2024 | -1.79% | $ 34.83M | $ 622K |
9/30/2024 | -0.74% | $ 88.05M | $ 655.39K |
6/30/2024 | -1.35% | $ 62.31M | $ 841.11K |
3/31/2024 | -0.3% | $ 229.15M | $ 696.21K |
12/31/2023 | -0.25% | $ 217.79M | $ 535.2K |
9/30/2023 | -0.18% | $ 252.33M | $ 458.21K |
6/30/2023 | -0.13% | $ 247.11M | $ 316.12K |
3/31/2023 | -0.08% | $ 255.99M | $ 214.57K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for OVID THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 103.32M ]) / Market Cap [ $ 383.15M ]
(=) Buyback Yield [ -26.97% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.71% |